Skip to main content
. 2015 Jun 8;7:325–336. doi: 10.2147/CEOR.S80130

Figure 4.

Figure 4

(A) Probability of being cost-effective at different cost-effectiveness thresholds for IgE-mediated allergy infants, from the perspective of the INHS. (B) Probability of being cost-effective at different cost-effectiveness thresholds for non-IgE-mediated allergy infants, from the perspective of the INHS.

Abbreviations: AAF, amino acid formula; eHCF, extensively hydrolyzed casein formula; HRF, hydrolyzed rice formula; INHS, Italian National Health Service; LGG, Lactobacillus rhamnosus GG; SBF, soy-based formula.